doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
These visits allow your provider to monitor progress, review tolerance, adjust treatment plans when needed, and ensure your care remains safe and effective over your time with us
Be cautious with temperature changes
Its an easy one to miss
This batch of 5-Amino-1MQ Peptide has been third-party laboratory tested and verified for quality and consistency
Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity